Literature DB >> 10204584

A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets.

N M Heddle1, L Klama, R Meyer, I Walker, L Boshkov, R Roberts, S Chambers, L Podlosky, P O'Hoski, M Levine.   

Abstract

BACKGROUND: Recent data suggest that most reactions to platelets are caused by white cell (WBC)-derived cytokines that accumulate in the plasma portion of the component during storage. On the basis of this theory, the effectiveness of two interventions to prevent reactions, poststorage WBC reduction and plasma depletion, were compared. STUDY
DESIGN: A multiple crossover design was used, in which platelet components for transfusion to a patient randomly were WBC reduced after storage, or the plasma supernatant was removed. Adults >17 years of age, with a hematologic disease requiring platelet transfusion support, were eligible for the study. Patients were assessed for signs and symptoms characteristic of a reaction during, immediately after, and 1 hour after transfusion. Reactions were graded as mild, moderate, or severe. Interleukin 6 levels were also measured in the transfused platelet components.
RESULTS: There were 380 analyzable platelet transfusions to 30 patients. The frequency of reactions was 25.8 percent (48/186) in the transfusions of poststorage WBC-reduced platelets and 17.0 percent (33/194) in the transfusions of plasma-depleted platelets (p<0.008). The severity of the reaction was graded by the patient. Severe reactions occurred more frequently in connection with poststorage WBC-reduced platelets than with plasma-depleted platelets: 33.4 percent (16/48) versus 18.2 percent (6/33), respectively (p = 0.048). Regression analysis identified interleukin 6 as the most significant of the evaluated factors in its correlation with the risk of reaction.
CONCLUSION: Plasma removal is more effective than poststorage WBC reduction in preventing reactions, especially severe reactions to platelets.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204584     DOI: 10.1046/j.1537-2995.1999.39399219278.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  15 in total

1.  Evaluation of White Blood Cell- and Platelet-Derived Cytokine Accumulation in MIRASOL-PRT-Treated Platelets.

Authors:  Susanne M Picker; Alexander Steisel; Birgit S Gathof
Journal:  Transfus Med Hemother       Date:  2009-03-04       Impact factor: 3.747

2.  Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.

Authors:  William J Savage; Jessica H Savage; Aaron A R Tobian; Chris Thoburn; Robert G Hamilton; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2011-08-29       Impact factor: 3.157

Review 3.  The hazards of blood transfusion in historical perspective.

Authors:  Harvey J Alter; Harvey G Klein
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

Review 4.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

5.  Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert G Hamilton; Paul M Ness
Journal:  Transfusion       Date:  2011-05-13       Impact factor: 3.157

6.  Recognition, Investigation and Management of Acute Transfusion Reactions: Consensus guidelines for Oman.

Authors:  Arwa Z Al-Riyami; Sabria Al-Hashmi; Zainab Al-Arimi; Louis D Wadsworth; Abdulhakim Al-Rawas; Murtadha Al-Khabori; Shahina Daar
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

7.  Pilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates.

Authors:  Iyonna Woods; Abdul Tawab-Amiri; Karen Byrne; Marianna Sabatino; David F Stroncek
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

8.  Desensitization in allergic transfusion reactions: evidence from the Trial to Reduce Alloimmunization to Platelets.

Authors:  William Savage; Aaron A R Tobian; Paul M Ness; Richard M Kaufman
Journal:  Transfusion       Date:  2014-02       Impact factor: 3.157

9.  Sporadic leukoreduction filter failure during red blood cell component preparation: beware of rapid filtration.

Authors:  Jeanne K Wang; Sherry L Sheldon; Harvey G Klein; Susan F Leitman; David F Stroncek
Journal:  Transfusion       Date:  2008-08       Impact factor: 3.157

Review 10.  Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon J Stanworth; Carolyn Doree; Sally Hopewell; Marialena Trivella; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.